Marriott (MAR) Offering Possible 25% Return Over the Next 30 Calendar Days

Marriott's most recent trend suggests a bullish bias. One trading opportunity on Marriott is a Bull Put Spread using a strike $90.00 short put and a strike $80.00 long put offers a potential 25% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $90.00 by expiration. The full premium credit of $2.00 would be kept by the premium seller. The risk of $8.00 would be incurred if the stock dropped below the $80.00 long put strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Marriott is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Marriott is bullish.

The RSI indicator is at 72.74 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Marriott

If You Invested $10,000 in Marriott in January, Here's What Your Shares Would Be Worth Now
Mon, 17 Aug 2020 15:16:34 +0000
Coronavirus hit Marriott International (NASDAQ: MAR) stock like a proverbial tons of bricks. In Q1, when the virus first emerged in the U.S. (Marriott does 79% of its business within U.S. borders), the company's sales dropped 30%.

Barclays Raises Marriott’s PT Amid Travel Demand Bet
Mon, 17 Aug 2020 12:52:26 +0000
Barclays increased Marriott’s price target to $108 (12.5% upside potential) from $105 and reiterated a Buy rating, amid expectations for a recovery in travel demand once COVID-19 related health problems subside.Barclays analyst Anthony Powell wrote in a note to investors that Marriott’s (MAR) key financial metrics in the China region are “encouraging” and highlight a “number of signs of improvement". Powell is optimistic about sequential demand improvement in July across the North American region and hopes for more significant recovery once the health situation improves.Global travel restrictions have been hurting Marriott’s financials. On Aug. 9, the company reported that 2Q revenues plunged 72% to $1.46 billion year-on-year. For the quarter, the hospitality company posted an adjusted loss per share of $0.64 compared with adjusted EPS of $1.56 in the year-ago quarter.However, its revenue per available room (RevPAR) in the China region was a brighter spot. The key metric in China was down about 61%, compared to 84.4% decline for the whole company. All hotels in the country are now open and occupancy rates have reached approximately 60%, depicting normalizing conditions in the region.Overall, MAR has a Hold analyst consensus. The average price target of $100.45 implies upside potential of 4.6% to current levels. (See MAR stock analysis on TipRanks).Related News: Marriot Posts Wider-Than-Expected 2Q Loss, Sees ‘Gradual Recovery’ Wedbush Sticks To Hold On Nordstrom Ahead Of 2Q Results Barclays Lifts NetEase’s PT On Gaming Sales Growth Bet More recent articles from Smarter Analyst: * Piper Sandler Turns Bullish On BP, Lifts PT * BMO Capital Lifts Deere’s PT Ahead Of 3Q Results * CytoDyn Requests Covid-19 Emergency Use Approval For Leronlimab * Tencent Music Strikes Deal With Thailand’s GMM; Analyst Upgrades To Buy

Marriott's Cash Burn Eases; Now, It Just Needs Travelers
Sat, 15 Aug 2020 19:25:00 +0000
Upscale hotel franchisor Marriott International (NASDAQ: MAR) illustrated its ability to grind out a protracted recovery from the COVID-19 pandemic in its second quarter 2020 earnings released on Aug. 10. Revenue per available room (RevPAR) across Marriott's system of owned and franchised properties plunged 88.6% year over year as occupancy slumped and average daily rates also declined. Given its wide year-over-year swing from a healthy profit to a significant loss, Marriott investors should drill down a bit on the current quarter to assess the consumer discretionary stalwart's resilience going forward.

6 Underdog Stocks to Ride the Recovery
Fri, 14 Aug 2020 16:46:00 +0000
Jefferies highlights those stocks in a report Friday, calling them “underdogs” that look well-positioned to capitalize on a recovery. Boeing (ticker: BA), Marriott (MAR), Sysco (SYY), and Live Nation (LYV) all operate in industries that have been hit hard by the pandemic, but they have potential for significant gains versus consensus forecasts through 2022, Jefferies says. Two other underdog stocks that the firm likes are casino operator Caesars Entertainment (CZR) and day-care operator (BFAM) Family Solutions (BFAM).

Marriott and Hilton Upgraded to Buy on Resilience in Pandemic
Fri, 14 Aug 2020 16:33:00 +0000
Marriott and Hilton "are anchored by proven management teams and business models," Jefferies wrote in upgrading the hotel chains.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.